Dishman Carbogen Amcis Limited

NSE DCAL.NS

Dishman Carbogen Amcis Limited EBIT Margin for the year ending March 31, 2024: -0.14%

Dishman Carbogen Amcis Limited EBIT Margin is -0.14% for the year ending March 31, 2024, a -112.98% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Dishman Carbogen Amcis Limited EBIT Margin for the year ending March 31, 2023 was 1.11%, a -45.64% change year over year.
Dishman Carbogen Amcis Limited EBIT Margin for the year ending March 31, 2022 was 2.05%, a 282.21% change year over year.
Dishman Carbogen Amcis Limited EBIT Margin for the year ending March 31, 2021 was -1.13%, a -108.88% change year over year.
Dishman Carbogen Amcis Limited EBIT Margin for the year ending March 31, 2020 was 12.68%, a -26.99% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NSE: DCAL.NS

Dishman Carbogen Amcis Limited

CEO	Mr. Pascal Villemagne
IPO Date	April 22, 2004
Location	India
Headquarters	Dishman Corporate House
Employees	1,132
Sector	Consumers Staples
Industries Cleaning Supplies Chemicals & Advanced Materials Cosmetics Drugstores & Retail Pharmacies Personal Care Petrochemicals Pharmaceuticals Plastics

Description

Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Key trends

Past 5 years